Your browser doesn't support javascript.
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19".
Rizk, John G; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R; Lavie, Carl J; Rizk, Youssef; Forthal, Donald N.
  • Rizk JG; Edson College, Arizona State University, Phoenix, AZ, USA. john.rizk@lau.edu.
  • Kalantar-Zadeh K; Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, School of Medicine, Irvine, CA, USA.
  • Mehra MR; Department of Epidemiology, University of California, Los Angeles, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
  • Lavie CJ; Tibor Rubin VA Long Beach Healthcare System, Long Beach, CA, USA.
  • Rizk Y; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Forthal DN; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine, New Orleans, LA, USA.
Drugs ; 80(14): 1501-1503, 2020 09.
Article in English | MEDLINE | ID: covidwho-743791
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Drugs Year: 2020 Document Type: Article Affiliation country: S40265-020-01396-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Drugs Year: 2020 Document Type: Article Affiliation country: S40265-020-01396-8